These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome. Sarkawi M; Raja Ali RA; Abdul Wahab N; Abdul Rathi ND; Mokhtar NM Sci Rep; 2024 Apr; 14(1):9478. PubMed ID: 38658619 [TBL] [Abstract][Full Text] [Related]
4. Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis. Zhang Y; Li L; Guo C; Mu D; Feng B; Zuo X; Li Y BMC Gastroenterol; 2016 Jun; 16(1):62. PubMed ID: 27296254 [TBL] [Abstract][Full Text] [Related]
5. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial. Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN Ceska Slov Farm; 2024; 72(5):233-241. PubMed ID: 38195431 [TBL] [Abstract][Full Text] [Related]
6. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial. Shanshal SA; Alsaaty MH; Al-Qazaz H; Al-Zidan RN Ceska Slov Farm; 2024; 73(1):233-241. PubMed ID: 38185646 [TBL] [Abstract][Full Text] [Related]
7. Irritable bowel syndrome in children: pathogenesis, diagnosis and evidence-based treatment. Sandhu BK; Paul SP World J Gastroenterol; 2014 May; 20(20):6013-23. PubMed ID: 24876724 [TBL] [Abstract][Full Text] [Related]
8. Role of Bacillus coagulans (Heyndrickxia coagulans)BCP92 in managing irritable bowel syndrome: A randomized, double-blind, multicenter, placebo-controlled clinical trial. Shaikh SS; Kumar S Medicine (Baltimore); 2024 Aug; 103(31):e39134. PubMed ID: 39093754 [TBL] [Abstract][Full Text] [Related]
9. How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome. Mercer M; Brinich MA; Geller G; Harrison K; Highland J; James K; Marshall P; McCormick JB; Tilburt J; Achkar JP; Farrell RM; Sharp RR J Clin Gastroenterol; 2012 Feb; 46(2):138-44. PubMed ID: 21716123 [TBL] [Abstract][Full Text] [Related]
10. Comments on Efficacy of a Synbiotic Containing Kim KW Gut Liver; 2023 Nov; 17(6):954-955. PubMed ID: 37967841 [No Abstract] [Full Text] [Related]
11. Clinical Utility of Probiotics Therapy in Managing Mycotoxin Illness. LaTouche L Integr Med (Encinitas); 2023 Sep; 22(4):12-14. PubMed ID: 37752931 [No Abstract] [Full Text] [Related]
12. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial. Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590 [TBL] [Abstract][Full Text] [Related]
13. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial. Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297 [TBL] [Abstract][Full Text] [Related]
14. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome. Stevenson C; Blaauw R; Fredericks E; Visser J; Roux S Nutrition; 2014 Oct; 30(10):1151-7. PubMed ID: 25194614 [TBL] [Abstract][Full Text] [Related]
15. Randomised clinical trial: A liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome--a 12 week double-blind study. Sisson G; Ayis S; Sherwood RA; Bjarnason I Aliment Pharmacol Ther; 2014 Jul; 40(1):51-62. PubMed ID: 24815298 [TBL] [Abstract][Full Text] [Related]
16. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial. Abbas Z; Yakoob J; Jafri W; Ahmad Z; Azam Z; Usman MW; Shamim S; Islam M Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):630-9. PubMed ID: 24722560 [TBL] [Abstract][Full Text] [Related]
17. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients. Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932 [TBL] [Abstract][Full Text] [Related]
18. A randomised controlled trial of a probiotic 'functional food' in the management of irritable bowel syndrome. Roberts LM; McCahon D; Holder R; Wilson S; Hobbs FD BMC Gastroenterol; 2013 Mar; 13():45. PubMed ID: 23496803 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial. Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913 [TBL] [Abstract][Full Text] [Related]
20. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]